for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Novavax begins participant crossover in two COVID-19 vaccine trials

April 5 (Reuters) - Novavax Inc on Monday said it had begun to crossover patients in its ongoing COVID-19 vaccine trials in South Africa and the UK to ensure participants who previously received placebo also receive active vaccine. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up